---
category: news
title: "Metis Therapeutics emerges with $86M for 2022 clinic entry, push into gene therapy"
excerpt: "Metis Therapeutics launched with $86 million to test its lead candidate in an early-2022 clinical trial and to bankroll the in-licensing of new assets. The small-molecule and RNA therapeutics biotech will also expand into CRISPR and gene therapy delivery in the coming year."
publishedDateTime: 2021-12-07T10:00:00Z
originalUrl: "https://www.fiercebiotech.com/biotech/metis-therapeutics-emerges-86m-for-2022-clinic-entry-push-into-gene-therapy"
webUrl: "https://www.fiercebiotech.com/biotech/metis-therapeutics-emerges-86m-for-2022-clinic-entry-push-into-gene-therapy"
type: article
quality: 33
heat: 33
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1638825497/Chris.jpg?VersionId=ebQfvaTvVaX7Xl_bUYgXrxTN9opHCYN_"
    width: 2048
    height: 2048
    isCached: true

secured: "GoTRDtHKjUbByx/x8nlkhBVnaMjDeaLU+p4RYjx5UWRy1ivjiMJHXdGfnFnP8RBnFqwKdGK+1cRnwPU1iQZ/ipk5zvZ846tGpUUkttyKkkISDLrcwr6XQOqQ0AbBMJYxMRDP0MLfOrcWUV80FHnCJtDLVE8qF1/4McUWXREkb2ZaLYKdDfWBazWm5pygz1aRETUw+r0ROyWROwMk4az4ofvDEJkh85xOH7HPUkbB6v9/eVwwm0I/zUC8oVUzTXOcnnT1J5WLpdDjVcHsdLuDXLIIzOTZ/EVn2jWKpmqO6ZcxCxPiFnN0fREUsdGp9QgQw+gjLK+hLPRZ8mioc/vDyYSRbz8mG814ebaQDxsJUWw=;d54PnWnD6RC2eh5qxJj2MQ=="
---

